Asia Pacific Cervical Cancer Diagnostic Testing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (PAP Testing, HPV Testing, Colposcopy, Cervical Biopsies, Cystoscopy, and Others) and Service Provider (Diagnostics and Research Laboratories, Hospitals and Clinics, Specialty Clinics, and Home Care Services)     

Code: TIPRE00027454 | Pages: 133 | Industry: Medical Device | Date: Mar 2022 | Type: Regional

The APAC cervical cancer diagnostic testing market is expected to grow from US$ 936.22 million in 2021 to US$ 1,351.28 million by 2028; it is estimated to grow at a CAGR of 5.4% from 2021 to 2028.

Healthcare players concentrate on several countries, owing to the large population suffering from cancer in these countries. Moreover, with rising production costs against their practices, these companies strive to produce sufficient revenue to entertain their investors. Having presence in growing countries offers reliable and profitable growth opportunities to the major players to lower their operating costs and expand their geographic reach. Advancements in biotechnology have increased the demand for improved diagnostics based on analytical systems in the healthcare market in several countries; they are also easing the shift toward point of care diagnostics kits. Fields such as infectious disease testing, molecular oncology, and pharmacogenomics in several countries open new growth avenues. Hence, healthcare companies are targeting patients or consumers from several economies. Companies in the healthcare sector have been investing significant amounts of their revenue in R&D activities to develop better and advanced offerings and technologies. Several countries across the region are going at a good rate.  Several activities in the region propel the demand for metabolomics-related services. Thus, the rising prevalence of cancer and technological advancements in several economies are boosting the cervical cancer diagnosis test market and providing significant growth opportunities to the players operating in the APAC market.

 

In case of COVID-19, APAC is highly affected specially India. APAC countries are expecting to witness massive challenges due to increasing COVID-19. In light of the current economic scenario, healthcare companies have been badly impacted as a result of disease outbreaks. The outbreak has severely affected the tourism industry and imposed supply chain disruptions; moreover, low-income countries face additional challenges due to the shortage of healthcare infrastructure. Restrictive measures have been put forth in South Korea, Malaysia, Singapore, the Philippines, and India to prevent disease transmission. All these factors will impact the cervical cancer diagnostic test market for a short period of time.  The government and population in the region are more focused on the treatment of COVID 19. The hospitals, and surgical centers are open for only emergency services. China is specifically facing issues that this epidemic has caused, leading to disruption of the supply chain, projected decreases in revenue and sales within all industries, as well as the concerns of health within the production factories and other public spaces. As the medical tourism is declined in response to the pandemic to the regions like South Korea and Japan which has negative impact on the country’s revenues. Thus, it is expected to have a negative impact on the cervical cancer diagnostic test market.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC cervical cancer diagnostic testing market. The APAC cervical cancer diagnostic testing market is expected to grow at a good CAGR during the forecast period. 

 

APAC Cervical Cancer Diagnostic Testing Market Revenue and Forecast to 2028 (US$ Million)     

APAC Cervical Cancer Diagnostic Testing Market Revenue and Forecast to 2028 (US$ Million)     

Get more information on this report :

 

APAC Cervical Cancer Diagnostic Testing Market Segmentation           

APAC Cervical Cancer Diagnostic Testing Market – By Type

  • PAP Testing
  • HPV Testing
  • Colposcopy
  • Cervical Biopsies
  • Cystoscopy
  • Others

APAC Cervical Cancer Diagnostic Testing Market – By Service Provider

  • Diagnostics and Research Laboratories
  • Hospitals and Clinics
  • Specialty Clinics
  • Home Care Services

APAC Cervical Cancer Diagnostic Testing Market, by Country

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of APAC

APAC Cervical Cancer Diagnostic Testing Market - Companies Mentioned

  • Abbott
  • BD
  • Cooper Companies, Inc.
  • F. Hoffmann-La Roche Ltd.  
  • Femasys Inc.
  • Guided Therapeutics, Inc
  • Hologic, Inc.  
  • QIAGEN
  • Quest Diagnostics Incorporated   

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        APAC Cervical Cancer Diagnostic Testing Market – By Type

1.3.2        APAC Cervical Cancer Diagnostic Testing Market – By Service Provider

1.3.3        APAC Cervical Cancer Diagnostic Testing Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           APAC Cervical Cancer Diagnostic Testing Market – Market Landscape

4.1         Overview

4.2         APAC PEST Analysis

4.3         Experts Opinion

5.           APAC Cervical Cancer Diagnostic Testing Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Escalating Prevalence of Cervical Cancer

5.1.2        Surging HPV Infections

5.2         Market Restraints

5.2.1        Lack of Awareness about the Diagnosis and Treatment Methods

5.3         Market Opportunities

5.3.1        Growing Opportunities in Emerging Countries

5.4         Future Trends

5.4.1        Rising Development and Launch of Innovative Products

5.5         Impact Analysis

6.           Cervical Cancer Diagnostic Testing Market– APAC Analysis

6.1         APAC Cervical Cancer Diagnostic Testing Market Revenue Forecast and Analysis

7.           APAC Cervical Cancer Diagnostic Testing Market Analysis – By Type

7.1         Overview

7.2         APAC Cervical Cancer Diagnostic Testing Market, By Type, 2021 & 2028 (%)

7.3         PAP Testing

7.3.1        Overview

7.3.2        PAP Testing: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

7.4         HPV Testing

7.4.1        Overview

7.4.2        HPV Testing: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

7.5         Colposcopy

7.5.1        Overview

7.5.2        Colposcopy: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

7.6         Cervical Biopsies

7.6.1        Overview

7.6.2        Cervical Biopsies: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

7.7         Cystoscopy

7.7.1        Overview

7.7.2        Cystoscopy: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

7.8         Others

7.8.1        Overview

7.8.2        Others: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

8.           APAC Cervical Cancer Diagnostic Testing Market Analysis – By Service Provider

8.1         Overview

8.2         APAC Cervical Cancer Diagnostic Testing Market Share by Service Provider - 2021 & 2028 (%)

8.3         Diagnostics and Research Laboratories

8.3.1        Overview

8.3.2        Diagnostic Laboratories and Research Laboratories: Cervical Cancer Diagnostic Testing Market Revenue and Forecast to 2028 (US$ Million)

8.4         Hospitals and Clinics

8.4.1        Overview

8.4.2        Hospitals and Clinics: Cervical Cancer Diagnostic Testing Market Revenue and Forecast to 2028  (US$ Million)

8.5         Specialty Clinics

8.5.1        Overview

8.5.2        Specialty Clinics: Cervical Cancer Diagnostic Testing Market Revenue and Forecast to 2028 (US$ Million)

8.6         Home Care services

8.6.1        Overview

8.6.2        Home Care Services: Cervical Cancer Diagnostic Testing Market Revenue and Forecast to 2028 (US$ Million)

9.           APAC Cervical Cancer Diagnostic Testing Market – Country Analysis

9.1         APAC Cervical Cancer Diagnostic Test Market Revenue and Forecasts To 2028

9.1.1        Overview

9.1.3        APAC: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Country (%)

9.1.3.1          Japan: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

9.1.3.1.1          Overview

9.1.3.1.2          Japan: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

9.1.3.1.3          Japan: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Type (US$ Million)

9.1.3.1.4          Japan: Cervical Cancer Diagnostic Test Market, by Service Provider, 2019–2028 (US$ Million)

9.1.3.2          China: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

9.1.3.2.1          Overview

9.1.3.2.2          China: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

9.1.3.2.3          China: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Type US$ Million)

9.1.3.2.4          China: Cervical Cancer Diagnostic Test Market, by Service Provider, 2019–2028 (US$ Million)

9.1.3.3          India Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

9.1.3.3.1          Overview

9.1.3.3.2          India: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

9.1.3.3.3          India: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Type (US$ Million)

9.1.3.3.4          India: Cervical Cancer Diagnostic Test Market, by Service Provider, 2019–2028 (US$ Million)

9.1.3.4          South Korea: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

9.1.3.4.1          Overview

9.1.3.4.2          South Korea: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

9.1.3.4.3          South Korea: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Type (US$ Million)

9.1.3.4.4          South Korea: Cervical Cancer Diagnostic Test Market, by Service Provider, 2019–2028 (US$ Million)

9.1.3.5          Australia: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

9.1.3.5.1          Overview

9.1.3.5.2          Australia: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

9.1.3.5.3          Australia: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Type (US$ Million)

9.1.3.5.4          Australia: Cervical Cancer Diagnostic Test Market, by Service Provider, 2019–2028 (US$ Million)

9.1.3.6          Rest of APAC: Cervical Cancer Diagnostic Test Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.6.1          Overview

9.1.3.6.2          Rest of APAC: Cervical Cancer Diagnostic Test Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.6.3          Rest of APAC: Cervical Cancer Diagnostic Test Market, by Type, 2019–2028 (US$ Million)

9.1.3.6.4          Rest of APAC: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Service Provider (US$ Million)

10.        Impact Of COVID-19 Pandemic on APAC Cervical Cancer Diagnostic Testing Market

10.1      APAC: Impact Assessment of COVID-19 Pandemic

11.        APAC Cervical Cancer Diagnostic Testing Market–Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      F. Hoffmann-La Roche Ltd.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Abbott

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Quest Diagnostics Incorporated

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      QIAGEN

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Hologic, Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Femasys Inc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Guided Therapeutics, Inc

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Cooper Companies, Inc.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      BD

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             APAC Cervical Cancer Diagnostic Testing Market – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Japan: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Type (US$ Million)

Table 3.             Japan: Cervical Cancer Diagnostic Test Market, by Service Provider – Revenue and Forecast to 2028 (US$ Million)

Table 4.             China: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Type (US$ Million)

Table 5.             China: Cervical Cancer Diagnostic Test Market, by Service Provider – Revenue and Forecast to 2028 (US$ Million)

Table 6.             India: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Type (US$ Million)

Table 7.             India: Cervical Cancer Diagnostic Test Market, by Service Provider – Revenue and Forecast to 2028 (US$ Million)

Table 8.             South Korea: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Type (US$ Million)

Table 9.             South Korea: Cervical Cancer Diagnostic Test Market, by Service Provider – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Australia: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Type (US$ Million)

Table 11.          Australia: Cervical Cancer Diagnostic Test Market, by Service Provider– Revenue and Forecast to 2028  (US$ Million)

Table 12.          Rest of APAC: Cervical Cancer Diagnostic Test Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Rest of APAC: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Service Provider (US$ Million)

Table 14.          Organic Developments

Table 15.          Inorganic Developments

Table 16.          Glossary of Terms

 


LIST OF FIGURES

Figure 1.           APAC Cervical Cancer Diagnostic Testing Market Segmentation

Figure 2.           APAC Cervical Cancer Diagnostic Testing Market, By Country

Figure 3.           APAC Cervical Cancer Diagnostic Testing Market Overview

Figure 4.           PAP Testing Segment Held Largest Share of the Market in 2021

Figure 5.           China is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           APAC: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Impact Analysis of Drivers and Restraints Pertaining to APAC Cervical Cancer Diagnostic Testing Market

Figure 9.           APAC Cervical Cancer Diagnostic Testing Market Forecast to 2028

Figure 10.        APAC Cervical Cancer Diagnostic Testing Market, by Type, 2021 & 2028 (%)

Figure 11.        APAC Pap Testing: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        APAC HPV Testing: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        APAC Colposcopy: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        APAC Cervical Biopsies: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        APAC Cystoscopy: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        APAC Others: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        APAC Cervical Cancer Diagnostic Testing Market Share by Service Provider - 2021 & 2028 (%)

Figure 18.        APAC Diagnostic Laboratories and Research Laboratories: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 19.        APAC Hospitals and Clinics: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 20.        APAC Specialty Clinics: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 21.        APAC Home Care Services: Cervical Cancer Diagnostic Testing Market Revenue and Forecasts To 2028 (US$ Million)

Figure 22.        APAC Cervical Cancer Diagnostic Test Market Overview, by Country (2021)

Figure 23.        APAC: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028, By Country (%)

Figure 24.        Japan: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        China: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26.        India: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27.        South Korea: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28.        Australia: Cervical Cancer Diagnostic Test Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29.        Rest of APAC: Cervical Cancer Diagnostic Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Impact of COVID-19 Pandemic in APAC Country Markets

  1. Abbott
  2. BD
  3. Cooper Companies, Inc.
  4. F. Hoffmann-La Roche Ltd.
  5. Femasys Inc.
  6. Guided Therapeutics, Inc
  7. Hologic, Inc.
  8. QIAGEN
  9. Quest Diagnostics Incorporated       
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000